Protein drug formulation: Converting biologically active substances into stable pharmaceutical products
The clinical success of protein therapy depends on transforming inherently unstable, biologically active macromolecules into robust pharmaceutical products with acceptable shelf life and safety profiles. Unlike small-molecule drugs, proteins are susceptible to multiple physical and chemical degradation pathways - inclu...